A best-evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was, should the practicing interventionalist use manual aspiration systematically in all patients undergoing percutaneous coronary intervention (PCI) or only in selected patients with an angiographically obvious thrombotic burden? Altogether, 198 papers were found using the reported search, of which nine represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. We conclude that the evidence demonstrates that clinical and angiographic outcomes with respect to manual thrombectomy are similar and encouraging for patients with both angiographic evidence of thrombus burden and those in whom it is used routinely. In addition, there is no significant increase in major adverse cardiac events when routine use of manual aspiration is adopted as opposed to reserving its use for those patients with angiographic evidence of thrombus. In summary, the evidence supports the use of routine systematic manual aspiration in all patients undergoing primary PCI for ST-elevation myocardial infarction.
INTRODUCTION
A best-evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1] .
THREE-PART QUESTION
In patients [undergoing percutaneous coronary intervention] is [routine systematic manual aspiration superior] to [manual aspiration carried out only in those patients with angiographically obvious thrombotic burden]?
CLINICAL SCENARIO
You are a cardiac surgeon at the local cardiothoracic multidisciplinary meeting when a colleague, an interventional cardiologist, presents a complex case involving a patient with a ST-elevation myocardial infarction (STEMI). It is noted by the clinical director of your department that prior to treatment of the index patient, the cardiologist used a manual thrombectomy device to retrieve the clot despite there being no angiographically obvious thrombotic burden. He states it is a ludicrous practice to perform unnecessary interventions and that it should only be carried out if there is a visible thrombus that can be removed. The presenting cardiologist, taken aback, refutes the comment, stating that he uses manual aspiration for every STEMI case regardless of whether he can see an angiographically obvious thrombotic burden within the culprit vessel; he claims that in his experience, it improves his patient outcomes. A heated debate ensues with claims that this practice harks back to the dark days prior to evidence-based medicine and that there is no solid evidence base to support this practice. You resolve to check the literature yourself. This RCT showed that the use of manual thrombus aspiration before stenting during pPCI results in a lower cardiac mortality and a lower incidence of the cardiac death or non-fatal reinfarction 
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SEARCH OUTCOME
In total, 198 papers were found using the reported search. From these, nine papers were identified that provided the best evidence to answer the question. These are presented in Table 1 .
RESULTS
Dudek et al. [2] found that in STEMI patients who undergo routine manual systematic aspiration of thrombus against a standard percutaneous coronary intervention (PCI) strategy, there is an improvement in myocardial perfusion as assessed by myocardial blush grade (grade 3 rates 76.1 vs 57.8%, respectively, P = 0.026). A similar improvement in myocardial perfusion was found by Burzotta et al. [3] in their study of individuals with STEMI treated with manual thrombectomy and PCI or PCI alone (68 vs 44%, respectively [odds ratio 2.6; 95% confidence interval (CI) 1.1-6.2, P < 0.025]. Svilaas et al. [4] found, in their study of 1071 STEMI patients, that routine manual thrombectomy and PCI significantly reduced the number of cases with a post-procedural MBG of 0/1 when compared with standard PCI alone (17.1 vs 26.3%, respectively, P < 0.001). Encouragingly, the results obtained in these studies are comparable with those found by Sardella et al. [5] in patients with angiographic evidence of thrombus undergoing manual thrombectomy and standard PCI against PCI only (88 vs 59%, respectively, P < 0.0001). Ciszewski et al. [6] measured the myocardial salvage index (MSI) using sestamibi single photon emission computed tomography in their study of 137 patients with a visible thrombus on angiogram who underwent either manual thrombectomy or PCI only. They found that there was a significant increase in the MSI in the thrombectomy arm in comparison with the standard PCI arm [25.4% (IQR 13.5-44) vs 18.5% (IQR 7.7-30.3), respectively, P = 0.02].
Burzotta et al. [3] , Silva-Orrego et al. [7] and Svilaas et al. [4] studied the effects of routine manual thrombus aspiration in all individuals prior to PCI against a standard PCI strategy and its effects on ST segment resolution (STR) in the immediate aftermath of the procedure. Their sets of results, for a patient population totalling 1318 show similar improvements: Burzotta et al. [3] [58 vs 36.7% (odds ratio 2.4; 95% CI 1.1-5.3), P = 0.034], Silva-Orrego et al. [7] (68 vs 50%; P < 0.05) and Svilaas et al. [4] (56.6 and 44.2%; P < 0.001), for mechanical thrombectomy vs PCI alone. The results of immediate ST resolution in all individuals are similar to those obtained in the study by Sardella et al. [5] who assessed mechanical thrombectomy against standard PCI strategies in only those patients with angiographic evidence of visible clot burden. They found that resolution was achieved in 63 vs 39% (P < 0.001) for thrombectomy patients against the use of standard PCI, respectively.
Ciszewski et al. [6] showed that in their study of 137 patients with angiographic evidence of thrombus load undergoing manual thrombectomy against standard PCI, in-hospital mortality did not differ significantly, 3 vs 4% (P = 1.0) for thrombectomy vs standard PCI, respectively. A similar patient mortality rate of 4.5% from cardiac death following selective manual aspiration was found by Margheri et al. [8] in 129 consecutive patients treated with the Export catheter device.
Dudek et al. [2] found that in patients undergoing routine manual aspiration vs those undergoing standard PCI strategies, periprocedural complications were not significantly different between the two interventions (16 and 24.2%, respectively, P = 0.15). Burzotta et al. [3] and Silva-Orrego et al. [ 7] found there were no significant differences in the numbers of patients suffering early major adverse cardiovascular events (reinfarction, left ventricular failure and target vessel revascularization) between patients undergoing routine manual aspiration of thrombus and PCI and standard PCI treatment alone.
Sardella et al. [9] showed that in patients with a visible thrombus on angiogram cardiac death at 9 months and 2 years was 4.6% for standard PCI vs 0.0% for thrombectomy, (P = 0.023) and 6.8% for standard PCI vs 0.0% for thrombectomy, P = 0.012 respectively. This is a result similar to that found by Sardella et al., but in the case of STEMI patients undergoing routine manual aspiration and PCI vs those undergoing PCI only, Vlaar et al. [10] found a reduction in cardiac death at 1 year that was significant (3.6 vs 6.7% for thrombectomy vs standard PCI, respectively, hazard ratio 1.93, 95% CI 1.11-3.37, P = 0.020).
CLINICAL BOTTOM LINE
The evidence demonstrates that clinical and angiographic outcomes with respect to manual thrombectomy are similar and encouraging for both patients with angiographic evidence of thrombus burden and those in whom it is used routinely. In addition, there is no significant increase in major adverse cardiac events (MACE) when routine use of manual aspiration is adopted as opposed to reserving its use for those patients with angiographic evidence of thrombus. In summary, the evidence supports the use of routine systematic manual aspiration in all patients undergoing primary PCI for STEMI. It is important to note that two large randomized trials involving in excess of 4000 patients each led by Fröbert et al. [11] (TASTE trial) and Jolly and Džavík (TOTAL trial) [12] are investigating this particular clinical question and are due to report in 2014.
